Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy …

KF Huybrechts, G Bröms, LB Christensen… - JAMA …, 2018 - jamanetwork.com
Importance Given the rapidly increasing use of stimulant medications during pregnancy and
among women of reproductive age who may become pregnant inadvertently, there is a need …

[HTML][HTML] First-trimester exposure to methylphenidate: a population-based cohort study

A Pottegård, J Hallas, JT Andersen… - The Journal of clinical …, 2014 - psychiatrist.com
Objective: The use of methylphenidate to treat attention-deficit/hyperactivity disorder has
risen dramatically in Western countries, and it is increasingly used by adults, including …

Methylphenidate in pregnancy: a multicenter, prospective, comparative, observational study

O Diav-Citrin, S Shechtman, J Arnon… - The Journal of …, 2016 - legacy.psychiatrist.com
Introduction: Methylphenidate is a central nervous system stimulant medicinally used in the
treatment of attention-deficit disorder with or without hyperactivity (ADD/ADHD). Data on its …

Exposure to attention deficit hyperactivity disorder medications during pregnancy

C Humphreys, F Garcia-Bournissen, S Ito… - Canadian family physician, 2007 - cfp.ca
QUESTION An 18-year-old patient of mine, currently under treatment for attention deficit
hyperactivity disorder (ADHD) with methylphenidate, just found out that she is pregnant …

First Trimester In Utero Exposure to Methylphenidate

D Dideriksen, A PottegAard, J Hallas… - Basic & clinical …, 2013 - Wiley Online Library
Methylphenidate is a centrally acting sympathomimetic used for the treatment of attention
deficit/hyperactivity disorder in children and adolescents and for narcolepsy in adults …

Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis

NNN Ladhani, PS Shah, KE Murphy… - American journal of …, 2011 - Elsevier
OBJECTIVE: The aim of this study was to systematically review the relationship between
amphetamine exposure in pregnancy and birth outcomes. STUDY DESIGN: Electronic …

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy

SP Bro, MIS Kjaersgaard, ET Parner… - Clinical …, 2015 - Taylor & Francis
Objective To determine if prenatal exposure to methylphenidate (MPH) or atomoxetine (ATX)
increases the risk of adverse pregnancy outcomes in women with attention …

Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US

KF Huybrechts, L Straub, P Karlsson, L Pazzagli… - JAMA …, 2023 - jamanetwork.com
Importance Psychiatric disorders are common among female individuals of reproductive
age. While antipsychotic medication use is increasing, the safety of such medications in …

Placental complications associated with psychostimulant use in pregnancy

JM Cohen, S Hernández-Díaz, BT Bateman… - Obstetrics & …, 2017 - journals.lww.com
OBJECTIVE: To evaluate whether psychostimulants used to treat attention-
deficit/hyperactivity disorder (ADHD) are associated with risk of adverse placental …

Antipsychotic use in pregnancy and the risk for congenital malformations

KF Huybrechts, S Hernández-Díaz, E Patorno… - JAMA …, 2016 - jamanetwork.com
Importance The frequency of antipsychotic (AP) use during pregnancy has approximately
doubled during the last decade. However, little is known about their safety for the developing …